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Abstract
Vitamin A deficiency and malaria are both highly prevalent health problems in Africa. Vitamin A
deficiency affects over 30 million children, most of whom are in the age-group (under five years)
most affected by malaria. Vitamin A deficiency increases all-cause mortality in this part of the
population, and malaria is an important cause of death in children at this age. A low serum retinol
concentration (a marker of vitamin A deficiency) is commonly found in children suffering from
malaria, but it is not certain whether this represents pre-existing vitamin A deficiency, a
contribution of malaria to vitamin A deficiency, or merely an acute effect of malaria on retinol
metabolism or binding. In this paper, available evidence in support of a causal relationship in each
direction between vitamin A deficiency and malaria is reviewed. If such a relationship exists, and
especially if this is bidirectional, interventions against either disease may convey an amplified benefit
for health.
Background
Malaria commonly afflicts populations that are both
impoverished and malnourished, and a large proportion
of the burden of malaria falls upon children. There were
more than 100 million malaria episodes among young
children in sub-Saharan Africa in the year 2000, according
to a recent estimate [1]. Malaria is a preventable and easily
treatable disease, yet ~800,000 children die from it in
Africa every year [2]. Malaria is the commonest reason for
hospitalization among children and it is a leading con-
tributor to the widespread problem of anaemia [3].
Vitamin A is an essential nutrient required for maintain-
ing immune function, playing an important role in the
regulation of cell-mediated immunity and in humoral
antibody responses [4-6]. Vitamin A deficiency (VAD) is
an extended public health problem, especially in Africa
[7]. Preschool-age children and women of reproductive
age are the two population groups most at risk. Vitamin A
supplementation has been shown to decrease the inci-
dence of measles, diarrhoeal disease and all-cause mortal-
ity, as well as to improve several aspects of eye health [8-
14].
The relationship between malaria and VAD deserves care-
ful scrutiny. The available evidence associating VAD with
malaria is reviewed and discuss whether this association
may be causal and bidirectional.
Vitamin A sources and storage
Two main dietary forms of vitamin A exist: pre-formed
vitamin A, found in foods such as butter, egg yolks and
cod-liver oil, and provitamin A carotenoids, found in
foods such as spinach, carrots, mangoes and papayas.
Approximately 90% of the vitamin A in the body is stored
in the liver, and an adult liver can contain enough vitamin
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A to last more than 1 year. In developing countries a lower
than required dietary intake of vitamin A-rich foods com-
monly results in deficiency, especially among young chil-
dren [15].
Measuring vitamin A status
The most accurate measure of an individual's vitamin A
status is the hepatic vitamin A content. To assess this
requires an invasive technique that is impractical for pop-
ulation studies. Alternative methods for estimating VAD
at population level include measuring breast milk vitamin
A, dark adaptometry, pupillary responses, conjunctival
impression cytology and serum or plasma retinol concen-
tration [16]. Of these the latter has been most widely used,
especially in population studies, as an accessible indicator
of vitamin A status [17]. A circulating retinol concentra-
tion of <0.70 μmol/L (<20 μg/dl) is usually taken to indi-
cate deficiency in children [16]. The limitations of this
method, especially in the context of acute infection [18],
are discussed below.
Community prevalence of VAD
The prevalence of VAD (defined as serum retinol <0.70
μmol/L or the presence of abnormal impression cytology)
among African pre-school children in the year 2000 was
estimated to be 32%, affecting 33 million children
(Micronutrient Deficiency Information System [MDIS] of
the World Health Organization)[19]. The same and
linked studies revealed a prevalence of xerophthalmia of
1.5%, affecting an estimated 1.5 million children [17].
There is a scarcity of more recent information by which to
assess whether the prevalence of VAD has fallen in subse-
quent years during which there have been large-scale vita-
min A supplementation campaigns. Figure 1 shows the
most updated information on VAD for Africa using the
database generated by WHO with some more recent
national surveys [19]. Where an age-breakdown is pro-
vided, as in Malawi, VAD prevalence is highest among
young children (~60% in children aged 6–36 months)
and it decreases in older ages (~40% in children aged 6–
12 years).
Possible mechanisms of enhanced malaria susceptibility in 
VAD
The immune response against malaria involves both
innate and specific acquired immune mechanisms [20]. It
has been suggested that VAD impairs antibody response
to malarial antigens that require Th2-mediated help [21].
Vitamin A acts as a regulator of more than 300 genes
through its active metabolite, all-trans and 9-cis retinoic
acid, and specific nuclear receptors that are in the steroid
and thyroid hormone receptor superfamily [22].
Serghides et al [23] investigated the effects of 9-cis-retinoic
acid, a metabolite of vitamin A, on CD36 expression, non-
opsonic phagocytic clearance of parasitized erythrocytes,
and TNFα production in human monocytes and macro-
phages. The metabolite reduced secretion of TNFα, upreg-
ulated CD36 expression, and increased phagocytosis of
Plasmodium falciparum-parasitized erythrocytes. The
authors concluded that increased parasite clearance and
reduced proinflammatory cytokine responses to infection
might partly explain the beneficial effects of supplementa-
tion with vitamin A in malaria.
Does vitamin A supplementation decrease the risk of 
malaria?
Approximately two thirds [24] of the 10.8 million child
deaths [25] that currently occur can be prevented by avail-
able interventions, of which vitamin A supplementation
(VAS) is one. A meta-analysis of several large vitamin A tri-
als has shown that improving vitamin A status reduces
overall mortality rates by 23–34% among children six
months to five years of age if vitamin A supplementation
is given at least twice per year at coverage rates of at least
eighty percent [8,26,27]. The reduction in mortality was
particularly notable for measles (33–78%) and diarrhoea
(24–50%). The effect of vitamin A (% reduction in mor-
tality) does not seem to be influenced by age or gender in
children aged six months to five years. The most logical
explanation for these observations is that VAD increases
overall mortality and that it predisposes to some cause-
specific deaths.
Is malaria one of the conditions aggravated by VAD?
Binka et al [28] first investigated this question in two com-
panion, randomized, placebo controlled trials of the
impact of vitamin A supplementation on malaria parasi-
taemia, morbidity, and mortality in young children (aged
6–59 months) in northern Ghana. In the mortality study
21,906 children were visited every four months over a
period of two years, and in the morbidity study 1,455 chil-
dren were visited weekly for one year. The vitamin A dos-
ing regime was the same in the two trials: children aged 6–
11 months were randomized to receive either 30 mg reti-
nol or placebo and older children to receive either 60 mg
retinol or placebo every four months. Analysis of out-
comes showed a 20% reduction in all-cause mortality in
the groups receiving vitamin A, but no difference in iden-
tifiable malaria-specific mortality rates (RR = 1.03; 95%
CI 0.74, 1.43). Similarly, there was no evidence in this
study that supplementation reduced the incidence of
probable malarial fever (reported symptoms with no slide
confirmation), malaria parasitaemia or mean parasite
density in children with a positive blood smear. The inves-
tigators reported that there was no correlation between
serum retinol concentration at the beginning of the trial
and subsequent malaria parasite density in children who
received placebo (r = 0.01). It was then concluded that
vitamin A supplementation had no impact on malaria inMalaria Journal 2009, 8:134 http://www.malariajournal.com/content/8/1/134
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Distribution of vitamin deficiency in African pre-school children Figure 1
Distribution of vitamin deficiency in African pre-school children. Vitamin A deficiency is defined as serum retinol 
<0.70 μmol/L. These data are broadly based on surveys conducted during the year 2000 and 2003.
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this population, despite the 20% reduction in overall
mortality.
Different findings were reported in two subsequent rand-
omized controlled trials assessing the impact of vitamin A
supplementation on slide confirmed malaria. In a study
conducted in Papua New Guinea [29] 480 children aged
6–60 months were randomly assigned to receive high-
dose vitamin A or placebo every 3 months for 13 months.
Malaria morbidity was assessed both through weekly
community-based case detection and by surveillance of
patients who self-reported to the health centre. The
number of episodes of fever with parasitaemia (tempera-
ture 37.5°C with a parasite count of at least 8000/μl) was
30% lower in the vitamin A group than in the placebo
group (RR= 0.70; 95% CI 0.57, 0.87). Supplementation
also reduced the mean parasite density in these sympto-
matic cases, but had no effect on the incidence of P falci-
parum infection (parasitaemia of any density, irrespective
of symptoms) or anaemia. A recent randomized control-
led trial conducted in Burkina Faso [30] assessed the
impact of a single dose of 200,000 IU of vitamin A with
daily zinc supplementation for a period of six months on
148 children aged 6–72 months. Children in the supple-
mented group had a significant 30% reduction in slide-
confirmed malaria fevers.
Does malaria contribute to VAD?
Two major methodological challenges complicate any
attempt to assign to malaria a causal role in the develop-
ment of VAD. These are: (i) the lack of enough evidence
from prospective studies demonstrating that infection
precedes deficiency; and (ii) the fact that the serum retinol
concentration (the widely-used marker for vitamin A sta-
tus) may be affected as part of the host's acute phase
response to infection.
Associations have been reported between xerophthalmia
(the severest clinical manifestation of VAD) and a variety
of preceding acute illnesses, including diarrhoea, pneu-
monia and measles [31]. In one prospective study, chil-
dren who had suffered from diarrhoea or respiratory
disease were more likely to develop xerophthalmia subse-
quently [32]. These findings suggest that a reduction in
the serum retinol concentration may follow a variety of
acute infections, presumably mediated by a common host
response.
More data are available for this effect in malaria than in
other infections. In a recent large case-control study [33]
in Malawi, 92% of 247 severe anaemia cases (mostly
severe malarial anaemia) had low levels of serum retinol
versus 66% of 262 controls. This study also detected an
inverse association between serum retinol concentration
and malaria parasite density (unpublished data) which is
consistent with previous observations [34]. Other studies
also found that serum retinol levels were substantially
lower in individuals with malaria illness than in their
healthy peers. In a case control study [35] involving 454
pre-school age Congolese children, 37.5% of the children
suffering from malaria had plasma levels of retinol lower
than 10 μg/dl (0.3 μmol/L). The mean concentration of
plasma retinol in patients during malarial attacks (14.8 +/
- 9.5 μg/dl; or 0.5 +/- 0.3 μmol/L) was significantly lower
than the values found in control subjects (31.5 +/- 14.3
μg/dl; or 1.1 +/- 0.5 μmol/L) (p < 0.001). In seven non-
immune French adults suffering from malaria [36], serum
retinol levels were lower than in controls and correlated
inversely with the density of parasitaemia (r = -0 338, P =
0.035). In 24 Vietnamese adults with severe malaria,
serum retinol concentrations during the acute illness were
lower than in healthy controls, and increased significantly
during the first week after the start of treatment [37]
Investigations of this kind cannot demonstrate causality
nor its direction, and none of these studies evaluated vita-
min A status previous to the infection. An indirect attempt
to determine antecedent VAD in patients with malaria was
made in a study in Thailand, in which the mean serum
retinol concentration was lower in children with malaria
than in controls [38]. In this study the investigators did
not find evidence of clinical vitamin A deficiency in the
communities studied; they speculated, without convinc-
ing evidence, that severely depleted stores of retinol were
unlikely in the patients presenting with malaria. The
authors argued that the low serum retinol levels seen
might be attributed to the acute phase response of the
infection. This possibility is discussed below.
Mechanisms by which malaria could contribute to VAD
The observation that clinical malaria or even asympto-
matic parasitaemia is associated with low serum retinol
levels seems consistent across the studies referred to
above. However, it remains controversial whether the
reduction in retinol levels reflects an actual depletion of
vitamin A in the liver. A number of possible mechanisms
have been proposed by which malaria could lead to VAD
[5].
Decreased intake
Sick children tend to eat less, and malaria could precipi-
tate VAD in a child who is already malnourished and has
precarious hepatic reserves of vitamin A. This effect may
be enhanced by the fact that the malaria season is com-
monly a time when food supplies are scarce. There is evi-
dence that serum carotenes are depressed in malaria
patients independently of serum retinol concentrations,
suggesting preceding reduced oral intake of carotene-con-
taining compounds [38].Malaria Journal 2009, 8:134 http://www.malariajournal.com/content/8/1/134
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Malabsorption
There is an association between helminth infections and
malaria [39] and it has been suggested that helminth
infections may impair vitamin A uptake [40].
Direct loss
Urinary retinol losses during severe infection can be sub-
stantial. A study showed that adults in intensive care with
pneumonia and sepsis lose nearly three times the recom-
mended dietary allowance, whereas healthy adults lose
<1% of the recommended dietary allowance per day [41].
Impaired tubular reabsorption of low-molecular weight
proteins, including retinol-binding protein (RBP) may be
responsible for this [41,42]. It is not known whether or to
what extent malaria has this effect.
Impaired plasma carrying capacity
As part of the acute phase response [43] cytokines trigger
the induction of fever and production of cortisol and, in
the liver, increase the production of positive acute-phase
proteins while decreasing the production of negative
acute-phase proteins, including RBP [44]. RBP is the bind-
ing protein by which vitamin A is transported from the
liver to the tissues where it is required.
Is the plasma retinol concentration during an acute infec-
tious illness of any value as an indicator of an individual's
vitamin A status? A prospective study [45] assessing the
clinical and laboratory measurements at admission and
recovery of 90 children with dysentery (66 with shigello-
sis) hospitalized in Bangladesh showed that serum retinol
concentrations were low at admission, but were signifi-
cantly greater at discharge even though no vitamin A sup-
plements were given during the illness (0.36 +/- 0.22
compared with 1.15 +/- 0.50 μmol/L; or 10.3 +/- 6.3 com-
pared with 33 +/-14.3 μg/dl P < 0.001). The extent of this
increase was significantly associated with severity of dis-
ease and was greatest in children with poor underlying
nutritional status, particularly those with a low weight-
for-age. In Indian children with measles, it took eight
weeks on average after recovery from the acute illness for
normal concentrations of retinol and retinol binding pro-
tein to be restored [46]. There seems to be no data show-
ing whether or how soon retinol levels are restored after a
malaria infection has been eliminated, or of any investiga-
tions of the possibility that the low retinol levels in these
circumstances, even if transient, may further increase sus-
ceptibility to malaria or other infections.
Conclusion
The available evidence suggests that vitamin A supple-
mentation is a good strategy for children living in malaria-
endemic regions, because deficiency is common and
because supplementation reduces all-cause mortality.
Supplementation also reduces the incidence of vitamin A-
specific pathology such as xerophthalmia. Although vita-
min A supplementation reduces the incidence of uncom-
plicated malaria by about one-third, it does not appear to
reduce the rate of deaths that can be specifically attributed
to malaria. Evidence is weak for malaria having a causal
role in the development of VAD, although on theoretical
grounds and from indirect evidence this is a distinct pos-
sibility.
Current programmes that deliver separate interventions
against malaria and VAD may have a synergistic effect,
and coordination of these interventions may provide
added benefit against both diseases.
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